Award
NIH Reporter #2P50CA254838-06
The Memorial Sloan Kettering Cancer Center SPORE in Leukemia
Recipient
Sloan-Kettering Institute for Cancer Research
Award Amount
$3,031,373.00
Ceiling
$3,031,373.00
Awarded
September 17, 2026
Identifier
2P50CA254838-06
The National Cancer Institute awarded support for the Memorial Sloan Kettering Cancer Center SPORE in Leukemia to develop and test therapies for acute myeloid leukemia, including targeted treatments and CAR T-cell approaches.
Description
Funding supports research to develop targeted and immunotherapeutic approaches for acute myeloid leukemia, study treatment sensitivity and resistance, and improve patient outcomes. The program includes four research projects and shared resource and administrative cores.